Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1995 Jul;177(14):4140–4143. doi: 10.1128/jb.177.14.4140-4143.1995

Effects of growth rate and nutrient limitation on virulence factor production in Burkholderia cepacia.

D McKenney 1, D G Allison 1
PMCID: PMC177149  PMID: 7541788

Abstract

The influence of growth rate and oxygen availability on siderophore, protease, and lipase production in Burkholderia cepacia was assessed for cells grown in a chemostat under iron limitation. Whereas siderophore and protease production increased with growth rate and oxygen yet decreased under oxygen depletion, lipase production demonstrated the opposite trend.

Full Text

The Full Text of this article is available as a PDF (222.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison D. G., Goldsbrough M. J. Polysaccharide production in Pseudomonas cepacia. J Basic Microbiol. 1994;34(1):3–10. doi: 10.1002/jobm.3620340102. [DOI] [PubMed] [Google Scholar]
  2. Aronoff S. C., Quinn F. J., Jr, Stern R. C. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis. Pediatr Pulmonol. 1991;11(4):289–293. doi: 10.1002/ppul.1950110404. [DOI] [PubMed] [Google Scholar]
  3. Brown M. R., Collier P. J., Gilbert P. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother. 1990 Sep;34(9):1623–1628. doi: 10.1128/aac.34.9.1623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown M. R., Williams P. The influence of environment on envelope properties affecting survival of bacteria in infections. Annu Rev Microbiol. 1985;39:527–556. doi: 10.1146/annurev.mi.39.100185.002523. [DOI] [PubMed] [Google Scholar]
  5. Butler S. L., Nelson J. W., Poxton I. R., Govan J. R. Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis. FEMS Immunol Med Microbiol. 1994 May;8(4):285–292. doi: 10.1111/j.1574-695X.1994.tb00454.x. [DOI] [PubMed] [Google Scholar]
  6. Evans E., Brown M. R., Gilbert P. Iron chelator, exopolysaccharide and protease production in Staphylococcus epidermidis: a comparative study of the effects of specific growth rate in biofilm and planktonic culture. Microbiology. 1994 Jan;140(Pt 1):153–157. doi: 10.1099/13500872-140-1-153. [DOI] [PubMed] [Google Scholar]
  7. Gessner A. R., Mortensen J. E. Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Med Microbiol. 1990 Oct;33(2):115–120. doi: 10.1099/00222615-33-2-115. [DOI] [PubMed] [Google Scholar]
  8. Gilbert P., Stuart A. Small-scale chemostat for the growth of mesophilic and thermophilic microorganisms. Lab Pract. 1977 Aug;26(8):627–628. [PubMed] [Google Scholar]
  9. Gilbert P. The theory and relevance of continuous culture. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):1–6. doi: 10.1093/jac/15.suppl_a.1. [DOI] [PubMed] [Google Scholar]
  10. Govan J. R., Brown P. H., Maddison J., Doherty C. J., Nelson J. W., Dodd M., Greening A. P., Webb A. K. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993 Jul 3;342(8862):15–19. doi: 10.1016/0140-6736(93)91881-l. [DOI] [PubMed] [Google Scholar]
  11. HERBERT D., ELSWORTH R., TELLING R. C. The continuous culture of bacteria; a theoretical and experimental study. J Gen Microbiol. 1956 Jul;14(3):601–622. doi: 10.1099/00221287-14-3-601. [DOI] [PubMed] [Google Scholar]
  12. Holmes B. The identification of Pseudomonas cepacia and its occurrence in clinical material. J Appl Bacteriol. 1986 Oct;61(4):299–314. doi: 10.1111/j.1365-2672.1986.tb04291.x. [DOI] [PubMed] [Google Scholar]
  13. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  14. Koch C., Høiby N. Pathogenesis of cystic fibrosis. Lancet. 1993 Apr 24;341(8852):1065–1069. doi: 10.1016/0140-6736(93)92422-p. [DOI] [PubMed] [Google Scholar]
  15. Kooi C., Cox A., Darling P., Sokol P. A. Neutralizing monoclonal antibodies to an extracellular Pseudomonas cepacia protease. Infect Immun. 1994 Jul;62(7):2811–2817. doi: 10.1128/iai.62.7.2811-2817.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lewin C., Doherty C., Govan J. In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob Agents Chemother. 1993 Jan;37(1):123–125. doi: 10.1128/aac.37.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. LiPuma J. J., Dasen S. E., Nielson D. W., Stern R. C., Stull T. L. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet. 1990 Nov 3;336(8723):1094–1096. doi: 10.1016/0140-6736(90)92571-x. [DOI] [PubMed] [Google Scholar]
  18. Lodge J. M., Williams P., Brown M. R. Influence of growth rate and iron limitation on the expression of outer membrane proteins and enterobactin by Klebsiella pneumoniae grown in continuous culture. J Bacteriol. 1986 Feb;165(2):353–356. doi: 10.1128/jb.165.2.353-356.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lonon M. K., Woods D. E., Straus D. C. Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol. 1988 May;26(5):979–984. doi: 10.1128/jcm.26.5.979-984.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. May T. B., Shinabarger D., Maharaj R., Kato J., Chu L., DeVault J. D., Roychoudhury S., Zielinski N. A., Berry A., Rothmel R. K. Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev. 1991 Apr;4(2):191–206. doi: 10.1128/cmr.4.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McKenney D., Willcock L., Trueman P. A., Allison D. G. Effect of sub-MIC antibiotics on the cell surface and extracellular virulence determinants of Pseudomonas cepacia. J Appl Bacteriol. 1994 Feb;76(2):190–195. doi: 10.1111/j.1365-2672.1994.tb01615.x. [DOI] [PubMed] [Google Scholar]
  22. McKevitt A. I., Bajaksouzian S., Klinger J. D., Woods D. E. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun. 1989 Mar;57(3):771–778. doi: 10.1128/iai.57.3.771-778.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. McKevitt A. I., Woods D. E. Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol. 1984 Feb;19(2):291–293. doi: 10.1128/jcm.19.2.291-293.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Meyer J. M., Hohnadel D., Hallé F. Cepabactin from Pseudomonas cepacia, a new type of siderophore. J Gen Microbiol. 1989 Jun;135(6):1479–1487. doi: 10.1099/00221287-135-6-1479. [DOI] [PubMed] [Google Scholar]
  25. Nelson J. W., Butler S. L., Krieg D., Govan J. R. Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol. 1994 Feb;8(2):89–97. doi: 10.1111/j.1574-695X.1994.tb00430.x. [DOI] [PubMed] [Google Scholar]
  26. Schwyn B., Neilands J. B. Universal chemical assay for the detection and determination of siderophores. Anal Biochem. 1987 Jan;160(1):47–56. doi: 10.1016/0003-2697(87)90612-9. [DOI] [PubMed] [Google Scholar]
  27. Smith H. Pathogenicity and the microbe in vivo. The 1989 Fred Griffith Review Lecture. J Gen Microbiol. 1990 Mar;136(3):377–393. doi: 10.1099/00221287-136-3-377. [DOI] [PubMed] [Google Scholar]
  28. Sokol P. A., Lewis C. J., Dennis J. J. Isolation of a novel siderophore from Pseudomonas cepacia. J Med Microbiol. 1992 Mar;36(3):184–189. doi: 10.1099/00222615-36-3-184. [DOI] [PubMed] [Google Scholar]
  29. Sokol P. A. Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia. J Clin Microbiol. 1986 Mar;23(3):560–562. doi: 10.1128/jcm.23.3.560-562.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sokol P. A., Woods D. E. Effect of pyochelin on Pseudomonas cepacia respiratory infections. Microb Pathog. 1988 Sep;5(3):197–205. doi: 10.1016/0882-4010(88)90022-8. [DOI] [PubMed] [Google Scholar]
  31. Stephan H., Freund S., Beck W., Jung G., Meyer J. M., Winkelmann G. Ornibactins--a new family of siderophores from Pseudomonas. Biometals. 1993 Summer;6(2):93–100. doi: 10.1007/BF00140109. [DOI] [PubMed] [Google Scholar]
  32. Straus D. C., Lonon M. K., Hutson J. C. Inhibition of rat alveolar macrophage phagocytic function by a Pseudomonas cepacia lipase. J Med Microbiol. 1992 Nov;37(5):335–340. doi: 10.1099/00222615-37-5-335. [DOI] [PubMed] [Google Scholar]
  33. Thomassen M. J., Demko C. A., Klinger J. D., Stern R. C. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis. 1985 May;131(5):791–796. doi: 10.1164/arrd.1985.131.5.791. [DOI] [PubMed] [Google Scholar]
  34. Williams P., Brown M. R., Lambert P. A. Effect of iron deprivation on the production of siderophores and outer membrane proteins in Klebsiella aerogenes. J Gen Microbiol. 1984 Sep;130(9):2357–2365. doi: 10.1099/00221287-130-9-2357. [DOI] [PubMed] [Google Scholar]
  35. Wretlind B., Wadström T. Purification and properties of a protease with elastase activity from Pseudomonas aeruginosa. J Gen Microbiol. 1977 Dec;103(2):319–327. doi: 10.1099/00221287-103-2-319. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES